Staging Alzheimer's disease progression with multimodality neuroimaging

[1]  Harald Hampel,et al.  Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease , 2012, Neurobiology of Aging.

[2]  Klaus P. Ebmeier,et al.  A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease , 2011, Neurobiology of Aging.

[3]  Nick C. Fox,et al.  Biomarkers for Alzheimer's disease therapeutic trials , 2011, Progress in Neurobiology.

[4]  Harald Hampel,et al.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study , 2011, Human brain mapping.

[5]  Xue Hua,et al.  The effects of physical activity, education, and body mass index on the aging brain , 2011, Human brain mapping.

[6]  Vikas Singh,et al.  Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population , 2011, NeuroImage.

[7]  Paul M. Thompson,et al.  Genetics of white matter development: A DTI study of 705 twins and their siblings aged 12 to 29 , 2011, NeuroImage.

[8]  Arthur W Toga,et al.  Behavioral/Systems/Cognitive Amygdala Reactivity in Healthy Adults Is Correlated with Prefrontal Cortical Thickness , 2010 .

[9]  Massimo Filippi,et al.  Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease , 2010, Human brain mapping.

[10]  Paul M. Thompson,et al.  Genetics of microstructure of cerebral white matter using diffusion tensor imaging , 2010, NeuroImage.

[11]  Wanlin Zhu,et al.  White matter integrity in mild cognitive impairment: A tract-based spatial statistics study , 2010, NeuroImage.

[12]  Kiralee M. Hayashi,et al.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease , 2010, Neurobiology of Aging.

[13]  G. B. Frisoni,et al.  The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort , 2010, Neurobiology of Aging.

[14]  Michael W. Weiner,et al.  Obesity is linked with lower brain volume in 700 AD and MCI patients , 2010, Neurobiology of Aging.

[15]  Wendy R. Sanhai,et al.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.

[16]  K. Amunts,et al.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.

[17]  Thomas R. Barrick,et al.  White matter structural decline in normal ageing: A prospective longitudinal study using tract-based spatial statistics , 2010, NeuroImage.

[18]  David A Wolk,et al.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease , 2010, Proceedings of the National Academy of Sciences.

[19]  Amity E. Green,et al.  3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI , 2010, Human brain mapping.

[20]  Michael W. Weiner,et al.  A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly , 2010, Proceedings of the National Academy of Sciences.

[21]  Brian B. Avants,et al.  Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysis , 2010, NeuroImage.

[22]  C Caltagirone,et al.  When, where, and how the corpus callosum changes in MCI and AD , 2010, Neurology.

[23]  C. Rowe,et al.  Relationship between atrophy and β‐amyloid deposition in Alzheimer disease , 2010, Annals of neurology.

[24]  G. B. Frisoni,et al.  Functional compensation in incipient Alzheimer's disease , 2010, Neurobiology of Aging.

[25]  Maximilian Reiser,et al.  White matter microstructure underlying default mode network connectivity in the human brain , 2010, NeuroImage.

[26]  Paul M. Thompson,et al.  Mapping Gray Matter Development: Implications for Typical Development and Vulnerability to Psychopathology , 2022 .

[27]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[28]  S Ourselin,et al.  β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia , 2010, Neurology.

[29]  Paul M. Thompson,et al.  Fddnp Binding Using Mr Derived Cortical Surface Maps , 2022 .

[30]  Michael Weiner,et al.  Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease , 2009, Annals of neurology.

[31]  Harald Hampel,et al.  Diagnostic utility of novel MRI-based biomarkers for Alzheimer's disease: diffusion tensor imaging and deformation-based morphometry. , 2010, Journal of Alzheimer's disease : JAD.

[32]  Bram Stieltjes,et al.  Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. , 2010, Journal of Alzheimer's disease : JAD.

[33]  Bedda L. Rosario,et al.  Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.

[34]  Lisa H. Lu,et al.  Relationships between brain activation and brain structure in normally developing children. , 2009, Cerebral cortex.

[35]  Paul M. Thompson,et al.  Extending Genetic Linkage Analysis to Diffusion Tensor Images to Map Single Gene Effects on Brain Fiber Architecture , 2009, MICCAI.

[36]  A. Bokde,et al.  Assessing neuronal networks: Understanding Alzheimer's disease , 2009, Progress in Neurobiology.

[37]  R. Nitrini,et al.  The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? , 2009, Neuropathology and applied neurobiology.

[38]  Liana G. Apostolova,et al.  Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly , 2009, Molecular Imaging and Biology.

[39]  P. Sachdev,et al.  Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[40]  Bengt Långström,et al.  [11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients , 2009, Neurochemistry International.

[41]  Cindee M. Madison,et al.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.

[42]  G. Frisoni,et al.  In vivo mapping of amyloid toxicity in Alzheimer disease , 2009, Neurology.

[43]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[44]  G. Alexander,et al.  Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[45]  Akram Bakkour,et al.  The cortical signature of prodromal AD , 2009, Neurology.

[46]  Lawrence R. Frank,et al.  Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.

[47]  Vince D. Calhoun,et al.  A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data , 2009, NeuroImage.

[48]  Harald Hampel,et al.  White matter microstructure in relation to education in aging and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[49]  Michael Weiner,et al.  Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects , 2008, NeuroImage.

[50]  Katrin Amunts,et al.  Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain , 2008, NeuroImage.

[51]  Michael W. Weiner,et al.  The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium , 2008, Alzheimer's & Dementia.

[52]  Ricardo Nitrini,et al.  Assessment of factors that confound MRI and neuropathological correlation of human postmortem brain tissue , 2008, Cell and Tissue Banking.

[53]  Xiaoying Wu,et al.  Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.

[54]  Bradford C. Dickerson,et al.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies , 2008, Neuropsychologia.

[55]  Paul M. Thompson,et al.  Automated Ventricular Mapping with Multi-atlas Fluid Image Alignment Reveals Genetic Effects in Alzheimer's Disease , 2007 .

[56]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[57]  C. Jack,et al.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.

[58]  Kiralee M. Hayashi,et al.  3D mapping of language networks in clinical and pre-clinical Alzheimer’s disease , 2008, Brain and Language.

[59]  M. Viitanen,et al.  Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease , 2008, Annals of neurology.

[60]  Norbert Schuff,et al.  Neuropathological basis of magnetic resonance images in aging and dementia , 2008, Annals of neurology.

[61]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[62]  P. Thompson,et al.  O2-02-05 FDDNP-PET binding values from cortical hemispheric surface maps correlate with MMSE scores , 2007, Alzheimer's & Dementia.

[63]  C. Jack,et al.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.

[64]  Harald Hampel,et al.  Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study. , 2007, Brain : a journal of neurology.

[65]  Kiralee M. Hayashi,et al.  Structural Correlates of Apathy in Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[66]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[67]  C. Rowe,et al.  Imaging β-amyloid burden in aging and dementia , 2007, Neurology.

[68]  Kiralee M. Hayashi,et al.  The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.

[69]  Maximilian Reiser,et al.  Multivariate network analysis of fiber tract integrity in Alzheimer’s disease , 2007, NeuroImage.

[70]  A. Toga,et al.  Tracking Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[71]  N. Schuff,et al.  Headache and cerebral venous air embolism , 2007, Neurology.

[72]  Suzanne E. Welcome,et al.  Normal developmental changes in inferior frontal gray matter are associated with improvement in phonological processing: a longitudinal MRI analysis. , 2006, Cerebral cortex.

[73]  P. Thompson,et al.  PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.

[74]  K. Amunts,et al.  Towards multimodal atlases of the human brain , 2006, Nature Reviews Neuroscience.

[75]  H. Engler,et al.  Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. , 2006, Brain : a journal of neurology.

[76]  Vince D. Calhoun,et al.  Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.

[77]  Kiralee M. Hayashi,et al.  3D Mapping of Mini-mental State Examination Performance in Clinical and Preclinical Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[78]  A Drzezga,et al.  Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[79]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[80]  Paul M. Thompson,et al.  In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study , 2006, NeuroImage.

[81]  L. J. Whalley,et al.  White matter integrity and cognition in childhood and old age , 2006, Neurology.

[82]  Jim Mintz,et al.  Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. , 2006, Archives of general psychiatry.

[83]  M. Coleman.  Axon degeneration mechanisms: commonality amid diversity , 2005, Nature Reviews Neuroscience.

[84]  H. Möller,et al.  Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.

[85]  Brigitte Landeau,et al.  Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.

[86]  Y. Stern,et al.  APOE related alterations in cerebral activation even at college age , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[87]  C. Jack,et al.  Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.

[88]  Alan C. Evans,et al.  Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. , 2004, Cerebral cortex.

[89]  D. Mann,et al.  Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[90]  Simon B. Eickhoff,et al.  A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data , 2005, NeuroImage.

[91]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[92]  Nick C. Fox,et al.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.

[93]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[94]  L. Thal,et al.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease , 2004, Neurology.

[95]  Thomas F. Nugent,et al.  Dynamic mapping of human cortical development during childhood through early adulthood. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[96]  K. Herholz,et al.  Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[97]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[98]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[99]  M. Mesulam.  The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? , 2004, Learning & memory.

[100]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[101]  D. Dickson,et al.  Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2011 .

[102]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Y. Stern,et al.  APOE genotype and cerebral blood flow in healthy young individuals. , 2003, JAMA.

[104]  Suzanne E. Welcome,et al.  Mapping cortical change across the human life span , 2003, Nature Neuroscience.

[105]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[106]  Nick C Fox,et al.  Computer-assisted imaging to assess brain structure in healthy and diseased brains , 2003, The Lancet Neurology.

[107]  V. Challa,et al.  A three-dimensional study of brain string vessels using celloidin sections stained with anti-collagen antibodies , 2002, Journal of the Neurological Sciences.

[108]  Derek K. Jones,et al.  Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002 .

[109]  Susumu Mori,et al.  Fiber tracking: principles and strategies – a technical review , 2002, NMR in biomedicine.

[110]  J. Baron,et al.  Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment , 2002, Neuroreport.

[111]  Takashi Inoue,et al.  Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging , 2002, Neuroscience Letters.

[112]  Imran Akram,et al.  Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: Management and treatment import , 2002, American journal of Alzheimer's disease and other dementias.

[113]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[114]  A. Smith,et al.  Imaging the progression of Alzheimer pathology through the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J. Rapoport,et al.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J Mazziotta,et al.  A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[117]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[118]  G. Frisoni,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia , 2000, Journal of neurology, neurosurgery, and psychiatry.

[119]  C. Duyckaerts,et al.  Neuropathological aspects of Alzheimer disease , 1999 .

[120]  H. Braak,et al.  Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert , 2000, Acta Neuropathologica.

[121]  B. Reisberg,et al.  Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[122]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[123]  B. Reisberg,et al.  Towards a Science of Alzheimer's Disease Management: A Model Based Upon Current Knowledge of Retrogenesis , 1999, International Psychogeriatrics.

[124]  H. Gertz,et al.  Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain , 1998, Neuroscience.

[125]  M J Bronskill,et al.  Quantitative MR volumetry in Alzheimer's disease , 1997, Neurology.

[126]  R. Woods,et al.  Mapping Histology to Metabolism: Coregistration of Stained Whole-Brain Sections to Premortem PET in Alzheimer's Disease , 1997, NeuroImage.

[127]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[128]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[129]  Y. Stern,et al.  Preliminary Findings from the Predictors Study: Utility of Clinical Signs for Predicting Disease Course , 1995, Alzheimer disease and associated disorders.

[130]  M. Albert,et al.  Age at onset of Alzheimer's disease , 1994, Neurology.

[131]  J. Trojanowski,et al.  Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. , 1988, AJR. American journal of roentgenology.

[132]  J. Haxby,et al.  Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type , 1987, Neuropsychologia.

[133]  M. Hofman,et al.  Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions , 1986, Journal of Neuroscience Methods.

[134]  B. Seltzer,et al.  A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? , 1983, Archives of neurology.

[135]  H. Kretschmann,et al.  Different volume changes of cerebral cortex and white matter during histological preparation. , 1982, Microscopica acta.

[136]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.